Weiss RS - Search Results

1

Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies.

Aye Y, Li M, Long MJ, Weiss RS. Aye Y, et al. Among authors: weiss rs. Oncogene. 2015 Apr 16;34(16):2011-21. doi: 10.1038/onc.2014.155. Epub 2014 Jun 9. Oncogene. 2015. PMID: 24909171 Review.

2

Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms.

Xu X, Page JL, Surtees JA, Liu H, Lagedrost S, Lu Y, Bronson R, Alani E, Nikitin AY, Weiss RS. Xu X, et al. Among authors: weiss rs. Cancer Res. 2008 Apr 15;68(8):2652-60. doi: 10.1158/0008-5472.CAN-07-5873. Cancer Res. 2008. PMID: 18413732 Free PMC article.

3

Growth pattern analysis of murine lung neoplasms by advanced semi-automated quantification of micro-CT images.

Li M, Jirapatnakul A, Biancardi A, Riccio ML, Weiss RS, Reeves AP. Li M, et al. Among authors: weiss rs. PLoS One. 2013 Dec 23;8(12):e83806. doi: 10.1371/journal.pone.0083806. eCollection 2013. PLoS One. 2013. PMID: 24376755 Free PMC article.

4

HUS1 regulates in vivo responses to genotoxic chemotherapies.

Balmus G, Lim PX, Oswald A, Hume KR, Cassano A, Pierre J, Hill A, Huang W, August A, Stokol T, Southard T, Weiss RS. Balmus G, et al. Among authors: weiss rs. Oncogene. 2016 Feb 4;35(5):662-9. doi: 10.1038/onc.2015.118. Epub 2015 Apr 27. Oncogene. 2016. PMID: 25915840

5

Cladribine and Fludarabine Nucleotides Induce Distinct Hexamers Defining a Common Mode of Reversible RNR Inhibition.

Wisitpitthaya S, Zhao Y, Long MJ, Li M, Fletcher EA, Blessing WA, Weiss RS, Aye Y. Wisitpitthaya S, et al. Among authors: weiss rs. ACS Chem Biol. 2016 Jul 15;11(7):2021-32. doi: 10.1021/acschembio.6b00303. Epub 2016 May 20. ACS Chem Biol. 2016. PMID: 27159113 Free PMC article.

6

Nuclear RNR-α antagonizes cell proliferation by directly inhibiting ZRANB3.

Fu Y, Long MJC, Wisitpitthaya S, Inayat H, Pierpont TM, Elsaid IM, Bloom JC, Ortega J, Weiss RS, Aye Y. Fu Y, et al. Among authors: weiss rs. Nat Chem Biol. 2018 Oct;14(10):943-954. doi: 10.1038/s41589-018-0113-5. Epub 2018 Aug 27. Nat Chem Biol. 2018. PMID: 30150681 Free PMC article.

7

Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer.

Abril YLN, Fernandez IR, Hong JY, Chiang YL, Kutateladze DA, Zhao Q, Yang M, Hu J, Sadhukhan S, Li B, He B, Remick B, Bai JJ, Mullmann J, Wang F, Maymi V, Dhawan R, Auwerx J, Southard T, Cerione RA, Lin H, Weiss RS. Abril YLN, et al. Among authors: weiss rs. Oncogene. 2021 Mar;40(9):1644-1658. doi: 10.1038/s41388-020-01637-w. Epub 2021 Jan 21. Oncogene. 2021. PMID: 33479498 Free PMC article.

8

Genome maintenance defects in cultured cells and mice following partial inactivation of the essential cell cycle checkpoint gene Hus1.

Levitt PS, Zhu M, Cassano A, Yazinski SA, Liu H, Darfler J, Peters RM, Weiss RS. Levitt PS, et al. Among authors: weiss rs. Mol Cell Biol. 2007 Mar;27(6):2189-201. doi: 10.1128/MCB.01763-06. Epub 2007 Jan 12. Mol Cell Biol. 2007. PMID: 17220276 Free PMC article.

9

Loss of Hus1 sensitizes cells to etoposide-induced apoptosis by regulating BH3-only proteins.

Meyerkord CL, Takahashi Y, Araya R, Takada N, Weiss RS, Wang HG. Meyerkord CL, et al. Among authors: weiss rs. Oncogene. 2008 Dec 11;27(58):7248-59. doi: 10.1038/onc.2008.336. Epub 2008 Sep 15. Oncogene. 2008. PMID: 18794804 Free PMC article.

10

A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity.

Jing H, Hu J, He B, Negrón Abril YL, Stupinski J, Weiser K, Carbonaro M, Chiang YL, Southard T, Giannakakou P, Weiss RS, Lin H. Jing H, et al. Among authors: weiss rs. Cancer Cell. 2016 Mar 14;29(3):297-310. doi: 10.1016/j.ccell.2016.02.007. Cancer Cell. 2016. PMID: 26977881 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page